Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis

BACKGROUND: Metformin use has been associated with a reduced risk of developing cancer and an improvement in overall cancer survival rates in meta-analyses, but, to date, evidence to support the use of metformin as an adjuvant therapy in individual cancer types has not been presented. PATIENTS AND M...

Descripción completa

Detalles Bibliográficos
Autores principales: Coyle, C., Cafferty, F. H., Vale, C., Langley, R. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5178140/
https://www.ncbi.nlm.nih.gov/pubmed/27681864
http://dx.doi.org/10.1093/annonc/mdw410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5178140/
https://www.ncbi.nlm.nih.gov/pubmed/27681864
http://dx.doi.org/10.1093/annonc/mdw410

Ejemplares similares